- Tension: Some people stay razor-sharp into their late 80s while others decline decades earlier despite doing ‘everything right’ — and scientists couldn’t explain the difference until now.
- Noise: The wellness industry has built a $50 billion empire around brain health supplements, apps, and diets, but the most powerful lever for cognitive longevity may be a single protein most people have never heard of — one your body already makes.
- Direct Message: The protein klotho doesn’t reward heroic interventions — it rewards the quiet, sustained conditions of a well-lived life. The breakthrough isn’t finding the molecule. It’s recognizing that the answer was biological all along, and building lives that let it work.
To learn more about our editorial approach, explore The Direct Message methodology.
Gloria Ramirez, 87, lives alone in a second-floor walkup in Queens. She does the New York Times crossword in pen every morning — the Saturday puzzle included. Her neurologist at Mount Sinai, who’s been tracking her cognitive function for eleven years, says her processing speed rivals that of most 50-year-olds. When her granddaughter asks what her secret is, Gloria shrugs. “I don’t forget things,” she says, as if that explains it. “I never have.”
Down the hall from Gloria’s doctor’s office, a filing cabinet holds brain scans belonging to another patient — a 64-year-old retired teacher named Dennis Park, who was diagnosed with mild cognitive impairment at 59. Dennis exercised religiously. He ate well. He read constantly. And still, something in his brain was quietly shutting down. Two patients in the same clinic, separated by twenty-three years of age, with dramatically different cognitive trajectories. The question that haunted Dennis’s neurologist wasn’t why Dennis was declining. It was why Gloria wasn’t.
That question — why some brains seem to resist aging while others succumb — has chased neuroscientists for decades. But a discovery published earlier this year may have cracked the code in a way nobody anticipated. And it centers on a single protein.
The protein is called klotho. Named after the Greek goddess who spins the thread of life, klotho was first identified in 1997 by researchers in Japan who noticed that mice engineered to lack the protein aged at a terrifying pace — organ failure, cognitive collapse, early death. Mice with elevated klotho levels, conversely, lived 20 to 30 percent longer. The findings were striking but remained confined to animal studies for years. What’s changed is that researchers at the University of California, San Francisco, led by neuroscientist Dena Dubal, have now demonstrated that injecting klotho into aging mice restores cognitive function — not just preserves it, but actively reverses deficits in learning and memory. The protein appears to enhance synaptic plasticity, the brain’s ability to form and strengthen connections between neurons.
As we explored in a recent piece on why some people stay mentally sharp into their 90s, the variation in how brains age isn’t random. It follows patterns. And klotho seems to be a major thread running through those patterns.
But the story gets more interesting — and more complicated — when you consider what klotho actually does inside the brain.
Nadia Osman, a 41-year-old biomedical researcher in Chicago, has spent three years studying klotho’s mechanism of action. She describes the protein not as a drug or a shield but as a “volume knob.” Klotho doesn’t block neurodegeneration the way a dam blocks water. Instead, it appears to modulate inflammation — dialing down the chronic, low-grade neural inflammation that accumulates with age, a process neuroscientists call “inflammaging.” This chronic inflammation erodes myelin sheaths, degrades synaptic connections, and slowly dismantles the architecture of cognition. Klotho seems to quiet that process at its source.
“We’ve been thinking about brain aging as a hardware problem — neurons dying, tissue shrinking,” Nadia told me. “Klotho suggests it might be more of a software problem. The hardware is still there. It’s just running in a hostile environment.”
That reframing matters enormously. If cognitive decline is primarily driven by an inflammatory environment rather than irreversible cell death, then intervention becomes theoretically possible at stages we previously considered too late. A 2023 study published in Nature Aging showed that even a single injection of a klotho fragment improved cognitive performance in aged primates — not just mice. The implications sent a jolt through the research community.
There’s a cultural dimension here too. We’ve built an entire wellness industry around brain health — supplements, apps, diets, puzzles. As we covered in our look at anti-aging supplements that may actually fuel cancer cell growth, much of what people do to “protect” their brains is based on incomplete science or outright marketing. The supplement industry generates over $50 billion annually in the U.S. alone. Klotho research doesn’t just challenge individual products — it challenges the entire framework. It suggests that the most powerful lever for brain health isn’t something you buy at a health food store. It’s something your body already makes — or fails to make — based on a complex interplay of genetics, environment, and lifestyle.
Marcus Delgado, a 52-year-old financial planner in San Diego, learned about klotho after his father was diagnosed with Alzheimer’s at 71. Marcus became, in his own words, “obsessed” with prevention. He spent thousands on nootropic supplements, meditation retreats, neurofeedback sessions. When he read about klotho, his reaction was a mix of hope and fury. “I’ve been doing everything the wellness world told me to do,” he said. “And it turns out the answer might be a protein I’ve never heard of that nobody’s selling yet.”
Marcus’s frustration points to something important. The gap between research and public understanding of brain aging is enormous. While scientists are mapping the precise molecular pathways of cognitive decline, most people are still operating on vague notions — “use it or lose it,” do crosswords, take fish oil. These aren’t wrong, exactly. Research on super agers shows that lifestyle genuinely matters. But lifestyle operates within a biological framework, and klotho appears to be one of the master regulators of that framework.
The timeline question is the one everyone wants answered. Dubal’s team at UCSF is cautious — clinical trials in humans are still in early stages, and translating animal results to human therapies has a long, humbling history of failure. But the optimism is real. Several biotech companies have already begun developing klotho-based therapeutics, and Dubal herself has suggested that meaningful clinical interventions could be tested within five to ten years. That’s not a cure-for-Alzheimer’s timeline. It’s a potentially-slow-down-or-reverse-age-related-cognitive-decline timeline, which, for the 55 million people worldwide living with dementia, feels almost as revolutionary.
There’s also a provocative connection to broader lifestyle research. People with naturally higher klotho levels tend to share certain habits — regular physical activity, strong social bonds, lower chronic stress. As we noted in our exploration of people over 80 who still produce new neurons, the habits that protect the brain often aren’t the dramatic interventions. They’re the quiet, sustained ones. Klotho may be the biological mechanism that explains why those habits work — a molecular translator between what you do every day and what happens inside your skull.
Gloria Ramirez doesn’t know what klotho is. She doesn’t take supplements or follow a special diet. She walks to the bodega every afternoon, argues with her neighbor about politics, calls her sister in Puerto Rico three times a week, and finishes that crossword. She sleeps well. She worries, but not excessively. She laughs at least once a day — the real kind, the kind that makes her eyes water.
If you could measure the klotho levels in Gloria’s blood — and researchers at multiple institutions are now developing tests to do exactly that — you’d likely find them elevated compared to the average for her age. Not because she did something heroic, but because her life, almost by accident, created the conditions for it.
That’s the part of this story that sits with me. We keep looking for the extraordinary answer — the miracle compound, the breakthrough pill, the one weird trick. And the science keeps pointing back to something quieter. The protein that may prevent brain aging exists inside you right now. The question was never whether it existed. The question was always whether we’d create lives that let it do its work.
Dennis Park, the retired teacher with mild cognitive impairment, enrolled in a new clinical study last fall. He doesn’t know if he’s in the treatment group or the placebo group. He told his wife it doesn’t matter. “For the first time,” he said, “someone is actually looking for the right thing.”
